Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk
Nadine Kabbani, John Olds
Molecular Pharmacology (2020) Vol. 97, Iss. 5, pp. 351-353
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
Stephany Beyerstedt, Expedito Barbosa Casaro, Érika Bevilaqua Rangel
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 5, pp. 905-919
Open Access | Times Cited: 737
The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains
Rongrong Chen, Keer Wang, Jie Yu, et al.
Frontiers in Neurology (2021) Vol. 11
Open Access | Times Cited: 476
A systematic review of neurological symptoms and complications of COVID-19
Xiangliang Chen, Sarah Laurent, Oezguer A. Onur, et al.
Journal of Neurology (2020) Vol. 268, Iss. 2, pp. 392-402
Open Access | Times Cited: 278
Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases
Lun Li, Çiğdem Acıoğlu, Robert F. Heary, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 740-755
Open Access | Times Cited: 222
SARS-CoV-2 Infectivity and Neurological Targets in the Brain
Walter J. Lukiw, Aileen I. Pogue, James M. Hill
Cellular and Molecular Neurobiology (2020) Vol. 42, Iss. 1, pp. 217-224
Open Access | Times Cited: 210
Neurological Insights of COVID-19 Pandemic
Gaurav Das, Nabanita Mukherjee, Surajit Ghosh
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 9, pp. 1206-1209
Open Access | Times Cited: 171
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury
Kai E. Swenson, Erik R. Swenson
Critical Care Clinics (2021) Vol. 37, Iss. 4, pp. 749-776
Open Access | Times Cited: 158
The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain
Rongrong Chen, Keer Wang, Jie Yu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 141
Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
Vikram Thakur, Radha Kanta Ratho, Pradeep Kumar, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 446-446
Open Access | Times Cited: 131
COVID-19: Pulmonary and Extra Pulmonary Manifestations
Islam Elrobaa, Karl J. New
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 119
Multiple Neuroinvasive Pathways in COVID-19
Dmitri Bougakov, Kenneth Podell, Elkhonon Goldberg
Molecular Neurobiology (2020) Vol. 58, Iss. 2, pp. 564-575
Open Access | Times Cited: 131
Anosmia in COVID-19: Mechanisms and Significance
Albert Y. Han, Laith Mukdad, Jennifer L. Long, et al.
Chemical Senses (2020) Vol. 45, Iss. 6, pp. 423-428
Open Access | Times Cited: 129
A Review of Neurological Complications of COVID-19
Mack Sheraton, Neha Deo, Rahul Kashyap, et al.
Cureus (2020)
Open Access | Times Cited: 113
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
Mohammad Azizur Rahman, Kamrul Islam, Saidur Rahman, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 3, pp. 1017-1023
Open Access | Times Cited: 112
Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?
Babak Sayad, Mahsa Sobhani, Reza Khodarahmi
Archives of Medical Research (2020) Vol. 51, Iss. 6, pp. 577-581
Open Access | Times Cited: 78
Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease
Geidy E. Serrano, Jessica E. Walker, Richard Arce, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 77
A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19
M. R. S. Hawkins, Sanjeev Sockalingam, Sarah Bonato, et al.
Journal of Psychosomatic Research (2020) Vol. 141, pp. 110350-110350
Open Access | Times Cited: 76
SARS-CoV-2: is there neuroinvasion?
Conor McQuaid, Molly Brady, Rashid Deane
Fluids and Barriers of the CNS (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 69
ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations
Vito S. Hernández, Mario A. Zetter, Enrique C. Guerra, et al.
Experimental Neurology (2021) Vol. 345, pp. 113837-113837
Open Access | Times Cited: 62
A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19
Jesús González-Rubio, Carmen Navarro-López, Elena López-Nájera, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 20, pp. 7394-7394
Open Access | Times Cited: 65
COVID-19 Vaccine: Critical Questions with Complicated Answers
Mohammad Faisal Haidere, Zubair Ahmed Ratan, Senjuti Nowroz, et al.
Biomolecules & Therapeutics (2020) Vol. 29, Iss. 1, pp. 1-10
Open Access | Times Cited: 64
Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes
Matteo Briguglio, Alberto Bona, Mauro Porta, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 63
Loss of Olfactory Function—Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders
Heike Rebholz, Ralf J. Braun, Dennis Ladage, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 63
Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients
Michael Zapor
Viruses (2020) Vol. 12, Iss. 12, pp. 1384-1384
Open Access | Times Cited: 61
Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke
Ji‐Young Choi, Hye‐Kyung Lee, Jung Hyun Park, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 528, Iss. 3, pp. 413-419
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top